New FDA approval for EGFR exon 19 and exon 21 L858R

October 9, 2024

Posted in FDA News, Science Made SimpleTagged #sciencemadesimple, EGFR, FDA

FDA approves alectinib for ALK+ NSCLC

May 14, 2024

Posted in FDA News, Research, Science Made SimpleTagged #sciencemadesimple, ALK

Recent FDA approval of combined therapy for initial treatment of EGFR-mutated NSCLC

March 15, 2024

Posted in FDA News, Research, Science Made SimpleTagged #fdaapprovals, #sciencemadesimple

FDA approves repotrectinib for patients with advanced ROS-1 fusion non-small cell lung cancer

January 12, 2024

Posted in FDA News, Research, Science Made SimpleTagged #sciencemadesimple

FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC

December 30, 2022

Posted in FDA News, Research, Science Made SimpleTagged #sciencemadesimple

FDA approves Imjudo with Imfinzi and chemo

November 22, 2022

Posted in FDA News, Research, Science Made SimpleTagged #sciencemadesimple

FDA approves drug for HER-2 unresectable or metastatic NSCLC

August 23, 2022

Posted in FDA News, Research, Science Made SimpleTagged #fdaapprovals, #sciencemadesimple, HER2

FDA approves nivolumab with chemotherapy as neoadjuvant treatment for certain patients with resectable NSCLC

March 7, 2022

Posted in FDA News, ResearchTagged #fdaapprovals, Research

Teliso-V granted FDA Breakthrough Designation for NSCLC

January 11, 2022

Posted in FDA News

2021 FDA approvals for lung cancer treatment

January 4, 2022

Posted in FDA NewsTagged #inthenews